Prevalence and associated factors of preeclampsia in two national university hospitals in Cotonou in 2024
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253504Keywords:
Associated factors, Cotonou, Preeclampsia, Pregnancy, PrevalenceAbstract
Background: Preeclampsia is one of the direct obstetric complications with a heavy burden, particularly in low- and middle-income countries such as Benin. The objective of this research was to identify the determinants of preeclampsia among pregnant women managed in two national university hospitals in Cotonou in 2024.
Methods: The study was conducted in two university hospitals in Cotonou. It was a matched case-control study (two controls for each case), with an analytical aim and prospective data collection from August to October 2024. The threshold for retaining variables in the bivariate analysis was 0.2. Multivariate analysis consisted of a stepwise descending binary logistic regression with a significance level of 0.05.
Results: A total of 120 cases of preeclampsia and 240 controls were surveyed. The hospital prevalence of preeclampsia was 11.11%. The mean age was 27.64±6.32 years versus 27.35±5.72 years. Most participants had secondary education (33.33% versus 42.50%) and were nulliparous (45.83% versus 35.42%). The majority of cases were referred (84.17%). Preeclampsia had several determinants: acceptance of the pregnancy by the partner (p=0.013), recent change of partner (p<0.001), existence of stress during pregnancy (p=0.006), nulliparity (p = 0.034), difficult living conditions (p=0.014), place of antenatal care (p<0.001), and multiple pregnancies (p=0.002).
Conclusions: Identifying the determinants of preeclampsia will make it possible to target appropriate interventions and preventive measures to reduce its incidence, tailor antenatal care, and improve the maternal and perinatal prognosis of this condition.
Metrics
References
Steegers, EAP, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44 DOI: https://doi.org/10.1016/S0140-6736(10)60279-6
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das TA, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Scientific Reports. 2021;11(1):21339. DOI: https://doi.org/10.1038/s41598-021-00839-w
Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2O22;27:148-69. DOI: https://doi.org/10.1016/j.preghy.2021.09.008
Anto EO, Boadu WIO, Ansah E, Tawiah A, Frimpong J, Tamakloe VCKT, et al. Prevalence of preeclampsia and algorithm of adverse foeto-maternal risk factors among pregnant women in the Central Region of Ghana: A multicentre prospective cross-sectional study. PLoS One. 2023;18(6):1‑14 DOI: https://doi.org/10.1371/journal.pone.0288079
Schneider S, Freerksen N, Maul H, Roehrig S, Fischer B, Hoeft B. “Risk groups and maternal-neonatal complications of preeclampsia- current results from the national German Perinatal Quality Registry” J Perinat Med. 2011;39:257-65. DOI: https://doi.org/10.1515/jpm.2011.010
Klungsoyr K, Morken NH, Irgens L, Vollset SE, Skjærven R. Secular trends in the epidemiology of preeclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival. Paediatr Perinat Epidemiol. 2012;26(3):190-8. DOI: https://doi.org/10.1111/j.1365-3016.2012.01260.x
Belay AS, Wudad T. Prevalence and associated factors of pre-eclampsia among pregnant women attending anti-natal care at Mettu Karl referral hospital, Ethiopia: cross-sectional study. Clin Hypertens. 2019;25(1):1‑8. DOI: https://doi.org/10.1186/s40885-019-0120-1
Guerrier G, Oluyide B, Keramarou M, Grais RF. Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. Int J Women’s Health. 2013;5:509. DOI: https://doi.org/10.2147/IJWH.S47056
Agrawal S. Prevalence and risk factors for symptoms suggestive of pre-eclampsia in Indian women. J Women’s Health Issues Care. 2014;3:2-9. DOI: https://doi.org/10.4172/2325-9795.1000169
Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40:213-20. DOI: https://doi.org/10.1038/hr.2016.126
Diallo MH, Diallo A, Diallo FB, Barry AB, Diakité M, Balde IS, et al. Preeclampsia: Socioeconomic, clinical, management and prognosis aspects at the maternity ward of the Labe-Guinea regional hospital. J SAGO. 2024;25(2):25-9.
Logan GG, Njoroge PK, Nyabola LO, Mweu MM. Determinants of preeclampsia and eclampsia among women delivering in county hospitals in Nairobi, Kenya. F1000Res. 2020;9:1‑16. DOI: https://doi.org/10.12688/f1000research.21684.1
Smiti Y, El Haddad H, El Bouti A, Hniad A, Slaoui A, Kharbach A, et al. Maternal-fetal complications of preeclampsia: a retrospective study of 136 cases. PAMJ-CM. 2021;7(25):1-6. DOI: https://doi.org/10.11604/pamj-cm.2021.7.25.26712
Khanum H, Akter K. Prevalence of pre-eclampsia and factors responsible among third trimester pregnant women in hospital of Dhaka. Biomed J Sci Tech Res. 2021;33(4):26089‑97. DOI: https://doi.org/10.26717/BJSTR.2021.33.005445
Reyes LM, García RG, Ruiz SL, Camacho PA, Ospina MB, Aroca G, et al. Risk factors for preeclampsia in women from Colombia: a case-control study. PLoS One. 2012;7(7):41622 DOI: https://doi.org/10.1371/journal.pone.0041622
Essome H, Koh VM, Ekono M, Boten M, Tocki TG, Foumane P, et al. Pre-eclampsia at Laquintinie Hospital (Douala): survey of prevalence and morbidity from 2010 to 2015. Health Sci Dis. 2019;20(5):8‑12.
Benjelloun AT, Benchrifi Y, Mahdaoui S, Samouh N. Epidemiology of preeclampsia in the greater Casablanca region. Pan Afr Med J. 2020;2(112):1‑10.
Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-92. DOI: https://doi.org/10.1016/S0029-7844(03)00475-7
Benjelloun AT, Benchrifi Y, Mahdaoui S, Samouh N. Epidemiology of preeclampsia in the greater Casablanca region. PAMJ Clin Med. 2020;2:112.
Leeners B, Neumaier-Wagner P, Kuse S, Stiller R, Rath W. Emotional stress and the risk to develop hypertensive diseases in pregnancy. Hypertens Pregnancy. 2007;26(2):211‑26. DOI: https://doi.org/10.1080/10641950701274870
Kordi M, Vahed A, Rezaee Talab F, Mazloum SR, Lotfalizadeh M. Anxiety during pregnancy and preeclampsia: a case-control study. J Midwife Reprod Health. 2017;5(1):814‑20.
Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy, the Jamaica Low Dose Aspirin Study Group. Br J Obstet Gynecol. 1998;105(3):293-9. DOI: https://doi.org/10.1111/j.1471-0528.1998.tb10089.x
World Health Organization. Preeclampsia. published on April 4, 2024. Available at: https://www.who.int/fr/news-room/fact-sheets/detail/pre-eclampsia. Accessed on 8 August 2025.
Olotu FI, Mahande JM, Renju J, Obure J. Prevalence and risk factors for preeclampsia/eclampsia in Northern Tanzania. J Public Health Epidemiol. 2020;12(2):78‑85. DOI: https://doi.org/10.5897/JPHE2019.1143
Al-Tairi ANQ, Isa ZM, Ghazi HF. Risk factors of preeclampsia: a case control study among mothers in Sana’a, Yemen. J Public Health. 2017;25(6):573‑80. DOI: https://doi.org/10.1007/s10389-017-0825-0